glp 1 agonist conversion chart Glucagon-like peptide-1 receptor: mechanisms and advances in therapy Mapping the effectiveness and risks
Description
16 ChenW.CaiP.ZouW.FuZ
Diabetes 58 , 461-P (2009)
doi: 10.1038/nchembio.209 76 DayJWGelfanovVSmileyDCarringtonPEEiermannGChicchiGet al
MHRA updates guidance for semaglutide prescribers and patients
The programme, effective since 1 January 2026 and currently rolled out at the Winter Olympic Games, states that markers of both semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide will be tracked in and out-of-competition to detect patterns of misuse
